SOLICI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SOLICI Trademark

Serial Number: 79378223 • Registration: 7477345

SOLICI is a trademark filed by Cambridge Healthcare Research Limited on July 3, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cambridge Healthcare Research Limited (2 trademarks)

St Johns Innovation Centre, Cowley Road

Entity Type: 99

Trademark Details

Filing Date

July 3, 2023

Registration Date

August 20, 2024

Published for Opposition

June 4, 2024

Goods & Services

Providing scientific and technological information, advice and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific research and analysis for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific and technological landscaping for the pharmaceutical, biopharmaceutical and medical device industries; quality control for others, namely, assessment and benchmarking of pharmaceutical, biopharmaceutical and medical device products; quality control for others, namely, researching, analysing and assessment of pharmaceutical, biopharmaceutical and medical device products for others; providing scientific information about pharmaceutical, biopharmaceutical and medical device products and companies; scientific research consulting, namely, preparing advice and reports on all the aforesaid

Providing business advice, information and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; providing business information about pharmaceutical, biopharmaceutical and medical device products and companies; market research for the pharmaceutical, biopharmaceutical and medical device industries; business research and market analysis for the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, strategic consulting and assistance with business decisions in the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, competitor landscaping, competitor monitoring, business competitive intelligence for the pharmaceutical biopharmaceutical and medical device industries; preparing reports on all the aforesaid

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
REFUSAL PROCESSED BY IB
May 8, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 29, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 28, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 27, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 27, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 27, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Sep 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR